DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "US Market Report for Continuous Glucose Monitoring 2017 - MedCore" report to their offering.
The U.S. continuous glucose monitoring (CGM) market can be segmented by setting, yielding two segments: professional CGM and personal CGM. In 2016, the largest segment in the total CGM market was the personal CGM segment. Growth is expected to continue over the forecast period and will be driven by favorable reimbursement, technological innovation and increased uptake of personal CGM among type 1 diabetics and insulin-dependent type 2 diabetics. Professional CGM is typically used in retrospective sessions initiated by physicians, during which a patient wears a CGM sensor for several days to a week, but is blinded to the real-time CGM data and must adhere to frequent self-monitoring of blood glucose (SMBG) using traditional blood glucose meters.
Additionally, the patient must maintain a record of their daily dietary intake and activity during the time that the sensor is worn. At the end of the session, the patient returns to their physician to remove the sensor and retrospectively analyze the glucose data that was collected. The blinded' aspect of professional CGM allows physicians to more easily assess their patient's behavior because their actions are not influenced by real-time' glucose data, as is the case with personal CGM products.
Key Topics Covered:
Table Of Contents I
List Of Figures Iii
List Of Charts V
U.S. Diabetes Monitoring, Treatment And Drug Delivery Market Overview
Procedure Codes Investigated
Key Report Updates
Johnson & Johnson
For more information about this report visit http://www.researchandmarkets.com/research/4kpqr3/us_market_report